Psychologists in La Follette, TN Accepting Medicare

2 Psychologists found. Showing 1 - 2

Dakota Aston Coltharp Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 198 E Bowman Cir, La Follette, TN 37766 Phone: 423-437-1340

Dr. Gary B Verna, PH.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 300 W Beech St, Rm 1, La Follette, TN 37766 Phone: 865-712-0234    Fax: 423-562-6106

News Archive

ACE2 receptors in the kidney not linked to high BP or RAS blockers

Even as the COVID-19 pandemic continues to smolder and flare up in various parts of the world, researchers are still trying to make sense of the virus, its routes of spread, its target tissues, and the immune responses it induces. One crucial piece of knowledge is that the primary viral receptor is a human enzyme called angiotensin-converting enzyme 2 (ACE2).

Concealment by British American tobacco industries

Leading public-health scientists writing in this week's issue of THE LANCET are calling for changes in the management of British American Tobacco's (BATs) UK information depository. This follows a detailed investigation which has highlighted how public access to industry records has been hampered by tight surveillance and inadequate search facilities at the depository in Guildford, UK.

Lombard Medical presents positive data from PYTHAGORAS PMA trial of Aorfix at VEITHsymposium

Lombard Medical, Inc., a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today presented efficacy and safety data from the two-year follow up of the U.S. PYTHAGORAS pre-marketing approval (PMA) trial of Aorfix, the first and only endovascular stent graft with global approvals for the treatment of patients with aortic neck angulations up to 90 degrees.

FDA Advisory Committee votes in favor of Cochlear Nucleus Hybrid L24 Implant System

Cochlear Limited, the global leader in implantable hearing solutions, announced today that an advisory committee to the US Food and Drug Administration voted favorably on the Cochlear Nucleus Hybrid L24 Implant System.

Read more Medical News

› Verified 8 days ago